These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10927752)

  • 41. Anticoagulation versus aspirin for geriatric patients with atrial fibrillation: is there still any doubt?
    Corvol A; Legendre C; Jean C; Lahjibi-Paulet H; Saint-Jean O; Somme D
    J Am Geriatr Soc; 2010 Feb; 58(2):398-400. PubMed ID: 20370874
    [No Abstract]   [Full Text] [Related]  

  • 42. Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.
    Steinberg BA; Greiner MA; Hammill BG; Curtis LH; Benjamin EJ; Heckbert SR; Piccini JP
    Cardiovasc Ther; 2015 Aug; 33(4):177-83. PubMed ID: 25930214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
    Bedeir K; Giugliano RP; Ramlawi B
    Int J Cardiol; 2016 Nov; 222():615-619. PubMed ID: 27521536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. When should I stop anticoagulation for atrial fibrillation?
    Greiver M
    CMAJ; 2005 May; 172(11):1437. PubMed ID: 15911854
    [No Abstract]   [Full Text] [Related]  

  • 45. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation.
    Hart RG; Pearce LA; Aguilar MI
    Ann Intern Med; 2007 Oct; 147(8):590-2. PubMed ID: 17938402
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Halperin JL; Hankey GJ; Wojdyla DM; Piccini JP; Lokhnygina Y; Patel MR; Breithardt G; Singer DE; Becker RC; Hacke W; Paolini JF; Nessel CC; Mahaffey KW; Califf RM; Fox KA;
    Circulation; 2014 Jul; 130(2):138-46. PubMed ID: 24895454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial fibrillation and cardioembolic stroke.
    Ferro JM
    Minerva Cardioangiol; 2004 Apr; 52(2):111-24. PubMed ID: 15194993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation.
    Copland M; Walker ID; Tait RC
    Arch Intern Med; 2001 Sep; 161(17):2125-8. PubMed ID: 11570942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrial fibrillation and anticoagulation.
    Marcus RR; Atwood JE
    Adv Intern Med; 1999; 44():239-65. PubMed ID: 9929711
    [No Abstract]   [Full Text] [Related]  

  • 51. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
    Lip GY; Edwards SJ
    Thromb Res; 2006; 118(3):321-33. PubMed ID: 16198396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
    Eckman MH; Wong LK; Soo YO; Lam W; Yang SR; Greenberg SM; Rosand J
    Stroke; 2008 Dec; 39(12):3308-15. PubMed ID: 18845797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation.
    Ling Z; Jia F; Xu Y; Su L; Liu Z; Du H; Yang X; Lan X; Xiao P; Chen W; Fan J; Luo S; Yin Y; Nazarian S
    Int J Cardiol; 2014 May; 173(2):345-6. PubMed ID: 24679686
    [No Abstract]   [Full Text] [Related]  

  • 54. Beyond warfarin: a patient-centered approach to selecting novel oral anticoagulants for stroke prevention in atrial fibrillation.
    Patel KK; Mehdirad AA; Lim MJ; Ferreira SW; Mikolajczak PC; Stolker JM
    J Hosp Med; 2014 Jun; 9(6):400-6. PubMed ID: 24715600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cerebral embolism and atrial fibrillation].
    Uesaka Y
    Brain Nerve; 2013 Jul; 65(7):761-9. PubMed ID: 23832979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anticoagulation in the elderly--a thin line between benefit and risk].
    Steffel J; Lüscher TF
    MMW Fortschr Med; 2009 Apr; 151(16):33-6. PubMed ID: 19658293
    [No Abstract]   [Full Text] [Related]  

  • 57. [Choice of antithrombotic therapy in atrial fibrillation, a daily challenge. No convincing evidence that warfarin is better than acetylsalicylic acid].
    Mooe T
    Lakartidningen; 2003 Aug; 100(34):2597-9, 2602-4. PubMed ID: 12968319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anticoagulation therapy of atrial fibrillation].
    Gjesdal K
    Tidsskr Nor Laegeforen; 2002 Jan; 122(2):191-2. PubMed ID: 11873577
    [No Abstract]   [Full Text] [Related]  

  • 59. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Healey JS
    Thromb Haemost; 2009 Nov; 102(5):912-3. PubMed ID: 19888528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.